Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer.
Sci Adv. 2020 Jan 15;6(3):eaax5032. doi: 10.1126/sciadv.aax5032. eCollection 2020 Jan.
Sci Adv. 2020.
PMID: 31998834
Free PMC article.